Current and future perspectives of liquid biopsies in genomics-driven oncology
Top Cited Papers
- 8 November 2018
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (2) , 71-88
Abstract
Precision oncology seeks to leverage molecular information about cancer to improve patient outcomes. Tissue biopsy samples are widely used to characterize tumours but are limited by constraints on sampling frequency and their incomplete representation of the entire tumour bulk. Now, attention is turning to minimally invasive liquid biopsies, which enable analysis of tumour components (including circulating tumour cells and circulating tumour DNA) in bodily fluids such as blood. The potential of liquid biopsies is highlighted by studies that show they can track the evolutionary dynamics and heterogeneity of tumours and can detect very early emergence of therapy resistance, residual disease and recurrence. However, the analytical validity and clinical utility of liquid biopsies must be rigorously demonstrated before this potential can be realized.Keywords
This publication has 175 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancerInternational Journal of Cancer, 2013
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- Detectable clonal mosaicism and its relationship to aging and cancerNature Genetics, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- MicroRNAs in body fluids—the mix of hormones and biomarkersNature Reviews Clinical Oncology, 2011
- Sensitive digital quantification of DNA methylation in clinical samplesNature Biotechnology, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004